S. Cochran

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

B. Morris, A. Egerton, L. Reid, 2008, Psychopharmacology.

PCP: from pharmacology to modelling schizophrenia.

B. Morris, S. Cochran, J. Pratt, 2005, Current opinion in pharmacology.

Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol

B. Morris, S. Cochran, J. Pratt, 2002, Neuropharmacology.

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

B. Morris, S. Cochran, J. Pratt, 2005, Schizophrenia Research.

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment

A. Egerton, S. Cochran, J. Pratt, 2008, British journal of pharmacology.

Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs

B. Morris, S. Cochran, J. Pratt, 2003, Neuropsychopharmacology.

Regionally selective alterations in local cerebral glucose utilization evoked by charybdotoxin, a blocker of central voltage‐activated K+‐channels

S. Cochran, J. Pratt, A. L. Harvey, 2001, The European journal of neuroscience.

Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain

B. Morris, S. Cochran, J. Pratt, 2002, Synapse.